EligibleTrials

BT-001 followed by Pembrolizumab (PD-1 Blocking Antibody): clinical trials recruiting now

Fewer than 3 recruiting trials found.

1
Recruiting trials
2
Conditions studied
0
US states with sites
1
Countries

Phase breakdown

Phase 1 1

Conditions being studied

ConditionTrials
Colorectal cancer1
Rectal Cancer Patients1

Recruiting trials involving BT-001 followed by Pembrolizumab (PD-1 Blocking Antibody)

Common questions

How many recruiting trials involve BT-001 followed by Pembrolizumab (PD-1 Blocking Antibody)?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.